Robert Stanley Sherwin MD

C. N. H. Long Professor of Medicine (Endocrinology); Section Chief, Endocrinology; Director, YCCI

Clinical Interests

Diabetes; hypoglycemia


Board Certifications

1972
Internal Medicine, Board Certified

Patient Care Locations

 
robert_sherwinfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Obesity and Insulin Resistance Neural Functioning of Feeding Centers in Obese Youth
Type 1 Diabetes The Effect of the Beta 2 Agonist, Formoterol, on Recovery from Hypoglycemia
Hypoglycemia The effect of opiate blockade with naltrexone on counterregulatory mechanisms in hypoglycemia
Autoantibody Positive, High Risk, Impaired Glucose Tolerance, and Non-diabetic Relatives at Risk for Type 1 Diabetes Anti-CD3 (Teplizumab) for Prevention of Diabetes in Relatives At-Risk for Type 1 Diabetes Mellitus
Abnormal Glucose Tolerance and Type 1 Diabetes CTLA-4 Ig (Abatacept) FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN RELATIVES AT-RISK FOR TYPE 1 DIABETES MELLITUS

More Clinical Trials...

Edit Profile